Cargando…
Xanthohumol, a Prenylated Flavonoid from Hops, Induces DNA Damages in Colorectal Cancer Cells and Sensitizes SW480 Cells to the SN38 Chemotherapeutic Agent
In spite of chemotherapy and systematic screening for people at risk, the mortality rate of colorectal cancer (CRC) remains consistently high, with 600,000 deaths per year. This low success rate in the treatment of CRC results from many failures associated with high resistance and the risk of metast...
Autores principales: | Scagliarini, Alessandra, Mathey, Aline, Aires, Virginie, Delmas, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226974/ https://www.ncbi.nlm.nih.gov/pubmed/32290112 http://dx.doi.org/10.3390/cells9040932 |
Ejemplares similares
-
Pharmacological Profile of Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus)
por: Liu, Ming, et al.
Publicado: (2015) -
Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.)
por: Jiang, Chuan-Hao, et al.
Publicado: (2018) -
Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus), Prevents Platelet Activation in Human Platelets
por: Lee, Ye-Ming, et al.
Publicado: (2012) -
Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro
por: Wei, Shanshan, et al.
Publicado: (2018) -
Xanthohumol, a Prenylated Flavonoid from Hops, Induces Caspase-Dependent Degradation of Oncoprotein BCR-ABL in K562 Cells
por: Lu, Xuxiu, et al.
Publicado: (2019)